The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The High-Fidelity Long-Read Sequencing Market In 2026 And 2030?

The high-fidelity long-read sequencing market size has seen substantial growth in recent years. It is expected to expand from $1.53 billion in 2025 to $1.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 22.2%. This historical growth can be attributed to several factors, including improvements in sequencing chemistry accuracy, initial adoption within genomics research institutions, the expansion of large-scale genome projects, increasing demand for structural variant analysis, and advancements in sequencing hardware performance.

The high-fidelity long-read sequencing market is projected to experience rapid expansion over the coming years. This market is anticipated to reach $4.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 22.5%. This expansion during the projected timeframe is driven by factors such as the increasing application of precision medicine, heightened investments in genomics-based drug discovery, the broadening scope of rare disease research, greater clinical implementation of long-read sequencing, and improvements in sequencing cost-effectiveness. Key trends for this period encompass the growing integration of long-read sequencing into clinical diagnostics, an escalating need for highly accurate variant detection, the expanding utilization of de novo genome assembly techniques, the widening range of epigenetic and transcriptomic analysis applications, and improved incorporation of advanced bioinformatics tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp

Which Growth Drivers Are Expected To Support The High-Fidelity Long-Read Sequencing Market Forward?

The growing prevalence of rare diseases is anticipated to drive the expansion of the HiFi long-read sequencing market moving forward. These rare conditions are disorders that impact a small number of individuals, often characterized by complex symptoms and limited treatment avenues. The increase in rare diseases is attributed to advancements in genetic sequencing and diagnostic technologies, which allow for earlier and more accurate identification of previously undiagnosed or misclassified conditions. HiFi long-read sequencing aids in tackling rare diseases by enabling highly accurate, exhaustive detection of intricate genetic variants frequently overlooked by short-read sequencing, thereby leading to faster and more precise diagnoses. For instance, in July 2023, according to the Department of Health & Social Care, a UK-based government department, it is estimated that more than 7,000 rare diseases exist, with new conditions continually being discovered as research advances. Approximately 80% of these rare diseases are known to have a genetic basis. Consequently, the rising occurrence of rare diseases is fostering the growth of the HiFi long-read sequencing market.

How Is Segment Classification Applied In The High-Fidelity Long-Read Sequencing Market?

The high-fidelity long-read sequencing market covered in this report is segmented –

1) By Product Type: Instruments; Consumables; Software

2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies

3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications

4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments

2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes

3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software

What Trends Are Influencing The Future Of The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the HiFi long-read sequencing market are focusing on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment refers to a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, allowing for focused, high-accuracy sequencing of target regions while reducing the analysis of non-relevant regions. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. This product uses hybrid-capture enrichment to enable precise long-read sequencing of complex genomic regions like repeats and structural variants, overcoming short-read limitations. These panels offer superior uniformity, specificity, and complete coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis. Benefits include streamlined efficiency and deeper insights for precision medicine.

Which Organizations Are Involved In The High-Fidelity Long-Read Sequencing Market?

Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.

Access The Complete High-Fidelity Long-Read Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report

Which Region Stands As The Largest Contributor To The High-Fidelity Long-Read Sequencing Market?

North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized High-Fidelity Long-Read Sequencing Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model